A systematic review and meta-analysis of incidence trends and risk factors for metachronous gastric lesions following endoscopic resection

内镜切除术后异时性胃病变发生率趋势及危险因素的系统评价和荟萃分析

阅读:1

Abstract

BACKGROUND AND AIMS: Metachronous gastric lesions (MGLs) are a significant concern after endoscopic resection (ER) for precancerous lesions and early gastric cancers (EGCs). The follow-up strategy for the development of MGLs after ER remains unclear. The aim of this study was to compare the trend in the cumulative MGL incidence after ER and to identify risk factors of MGLs. METHODS: We searched four databases (PubMed, Embase, Web of Science Core Collection and Cochrane Library) for studies reporting on patients who underwent ER, and performed meta-analysis. A dose-response analysis was performed to examine the association between follow-up time and cumulative MGL incidence after ER. RESULTS: Of the 423 studies initially retrieved, 18 studies were finally included in the meta-analysis. The overall cumulative MGL incidence after ER was 9.4% (95% confidence interval (CI) 7.2%-1.9%). The cumulative MGL incidence in China (5.4%, 95% CI: 4.1%-6.8%) was significantly lower than those in Korea (10.2%, 95% CI: 7.2%-13.5%) and Japan (9.0%, 95% CI: 7.0%-13.2%). Dose-response analysis showed that cumulative MGL incidence increased rapidly during 3-7 years follow-up after ER. Male gender (HR = 1.283, 95% CI: 1.029-1.601), older age (HR = 1.025, 95% CI: 1.010-1.040), Helicobacter pylori (H. pylori) infection (HR = 1.573, 95% CI: 1.048-2.362), severe intestinal metaplasia (IM) (HR = 3.423, 95% CI: 1.830-6.042) were significantly associated with MGLs after ER. CONCLUSIONS: Nearly 10% of patients develop MGLs after ER. Older age, persistent H. pylori infection, severe intestinal metaplasia, and male sex were independent risk factors. Given the increased incidence 3 year after ER, surveillance with intensified follow-up is necessary for high-risk patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。